Joel Greenblatt's CC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 66,370 shares of The Chemours Company (CC) worth $1.05 M, representing 0.00% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in CC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2019, adding 868,284 shares. Largest reduction occurred in Q4 2019, reducing 1.31 M shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's The Chemours Company (CC) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Chemours Company (CC) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2015 | +10,056 | New Buy | 10,056 | $5.37 |
| Q1 2016 | +480,925 | Add 4782.47% | 490,981 | $7.00 |
| Q2 2016 | +788,668 | Add 160.63% | 1.28 M | $8.24 |
| Q3 2016 | -663,133 | Reduce 51.82% | 616,516 | $16.00 |
| Q4 2016 | +337,415 | Add 54.73% | 953,931 | $22.09 |
| Q1 2017 | -741,132 | Reduce 77.69% | 212,799 | $38.50 |
| Q2 2017 | -182,987 | Reduce 85.99% | 29,812 | $37.90 |
| Q3 2017 | -12,015 | Reduce 40.30% | 17,797 | $50.63 |
| Q4 2017 | +348,094 | Add 1955.91% | 365,891 | $50.06 |
| Q1 2018 | -272,807 | Reduce 74.56% | 93,084 | $48.71 |
| Q2 2018 | -16,184 | Reduce 17.39% | 76,900 | $44.36 |
| Q3 2018 | +93,471 | Add 121.55% | 170,371 | $39.44 |
| Q4 2018 | +288,189 | Add 169.15% | 458,560 | $28.22 |
| Q1 2019 | +868,284 | Add 189.35% | 1.33 M | $37.16 |
| Q2 2019 | -1.33 M | Sold Out | 1.33 M | $0.00 |
| Q4 2019 | +17,735 | New Buy | 17,735 | $18.10 |
| Q1 2020 | +240,556 | Add 1356.39% | 258,291 | $8.87 |
| Q2 2020 | -5,925 | Reduce 2.29% | 252,366 | $15.35 |
| Q3 2020 | -43,085 | Reduce 17.07% | 209,281 | $20.91 |
| Q4 2020 | -30,810 | Reduce 14.72% | 178,471 | $24.79 |
| Q1 2021 | -61,245 | Reduce 34.32% | 117,226 | $27.91 |
| Q2 2021 | -59,428 | Reduce 50.70% | 57,798 | $34.79 |
| Q3 2021 | +28,733 | Add 49.71% | 86,531 | $29.06 |
| Q4 2021 | -16,578 | Reduce 19.16% | 69,953 | $33.57 |
| Q1 2022 | -14,365 | Reduce 20.54% | 55,588 | $31.48 |
| Q2 2022 | -1,630 | Reduce 2.93% | 53,958 | $32.02 |
| Q3 2022 | -7,911 | Reduce 14.66% | 46,047 | $24.65 |
| Q4 2022 | +4,976 | Add 10.81% | 51,023 | $30.62 |
| Q1 2023 | +2,458 | Add 4.82% | 53,481 | $29.94 |
| Q2 2023 | +334 | Add 0.62% | 53,815 | $36.89 |
| Q3 2023 | -11,079 | Reduce 20.59% | 42,736 | $28.05 |
| Q4 2023 | +75,454 | Add 176.56% | 118,190 | $31.54 |
| Q1 2024 | -82,769 | Reduce 70.03% | 35,421 | $26.26 |
| Q2 2024 | +3,462 | Add 9.77% | 38,883 | $22.57 |
| Q3 2024 | -26,870 | Reduce 69.10% | 12,013 | $20.32 |
| Q4 2024 | +1,894 | Add 15.77% | 13,907 | $16.90 |
| Q1 2025 | +40,565 | Add 291.69% | 54,472 | $13.53 |
| Q2 2025 | -41,335 | Reduce 75.88% | 13,137 | $11.45 |
| Q3 2025 | +53,233 | Add 405.21% | 66,370 | $15.84 |
Joel Greenblatt's The Chemours Company Investment FAQs
Joel Greenblatt first purchased The Chemours Company (CC) in Q4 2015, acquiring 10,056 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held The Chemours Company (CC) for 40 quarters since Q4 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to The Chemours Company (CC) was in Q1 2019, adding 1,326,844 shares worth $49.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 66,370 shares of The Chemours Company (CC), valued at approximately $1.05 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, The Chemours Company (CC) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in The Chemours Company (CC) was 1,326,844 shares, as reported at the end of Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.